BriaCell adds NYU cancer center to phase 3 breast cancer trial

May 7, 2026 7:30 AM

BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) announced the addition of NYU Langone Health's Perlmutter Cancer Center as a clinical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found